Personification of pharmacotherapy - the requirement of the time
Keywords:
cytochrome P450, gene polymorphism, MDR-1 gene, CYP2C19 gene, acid-dependent diseases of the digestive system, personification of pharmacotherapy.Abstract
The article notes that pharmacotherapy taking into account the patient's genotype is a young direction
that improves the safety and effectiveness of pharmacotherapy for acid-dependent diseases of the digestive system.
Determining the patient's genetic affiliation by polymorphisms of the MDR-1 and CYP2C19 genes makes it possible to
initially determine the tactics of treatment with proton pump inhibitors and other drugs in patients with acid-dependent
diseases, which serves as the basis for personifying the pharmacotherapy of diseases.
References
Максимов М.Л. и др. Общие вопросы клинической фармако- логии и фармакотерапии. – 2020. [Maksimov M. L. et al. General issues of clinical pharmacology and pharmacotherapy. – 2020.]
Очилов А.К., Мусаева Д. М. Особенности гена CYP2C19 для ин- дивидуализиции фармакотерапии //Новый день в медицине. – 2020. – №. 1. – С. 65-68. [Ochilov A.K., Musaeva D.M. Features of the CYP2C19 gene for individualization of pharmacotherapy // New day in medicine. – 2020. – no. 1. - S. 65-68.]
Очилова Г.С., Мусаева Д.М. Влияние полиморфизма гена MDR-1 на эффективность лечения хронического гастрита // Новый день в медицине. – 2020. – №. 1. – С. 309-312 [Ochilova G.S., Musaeva D.M. Influence of MDR-1 gene polymorphism on the effectiveness of treatment of chronic gastritis // New day in medicine. – 2020. – no. 1. - S. 309-312.]
Arvanitidis K. Genetic polymorphisms of drug-metabolizing enzymes CYP2D6, CYP2C9, CYP2C19 and CYP3A5 in the Greek population // К. Arvanitidis, G. Ragia, M. Iordanidou et al.// Fundam. Clin. Pharmacol. 2007. Vol. 21 №4. P. 419 - 426.
Efrén Martínez-Quintana, Fayna Rodríguez-González, José María Medina-Gil, Paloma Garay-Sánchez, Antonio Tugores // Actividad de CYP2C19 y factores de riesgo cardiovascular en pacientes con síndrome coronario agudo. Medicina Clínica. Volume 149. Issue 6. 2017. Pages 235-239.
Kim K.A., Park P.W., Park J.Y. Effect of ABCB1 (MDR1) haplotypes derived from G2677T/C3435T on the pharmacokinetics of amlodipine in healthy subjects//Br. J. Clin.Pharmacol. 2007, Jan. Vol.63, №1. P. 53–58.
Kim R. Drugs as P-glycoprotein substrates, inhibitors, and inducers. Drug Metab. Rev., 2012, 34, 47-54.
Klichova F.K., Mavlyanov I.R., Musaeva D.M. Influence of genes on pharmacotherapy of ulcer disease //Новый день в медицине. – 2020. – №. 2. – С. 147-150.
Мiguel A. López-García, Iris A. Feria-Romero, Héctor Serrano, Darío Rayo-Mares, Pietro Fagiolino, Marta Vázquez, Consuelo Escamilla-Núñez, Israel Grijalva, David Escalante-Santiago, Sandra Orozco-Suarez // Influence of genetic variants of CYP2D6, CYP2C9, CYP2C19 and CYP3A4 on antiepileptic drug metabolism in pediatric patients with refractory epilepsy. Pharmacological Reports. Volume 69. Issue 3. 2017. Pages 504-511.
Pharmacogenomics. Ed. M.Rothstein Willy-liss, New Jersey, 2003, 368 p.
P-Glycoprotein (ABCB1) expression in human skin is mainly restricted to dermal components / C. Skazik [et al.] // Exp Dermatol. – 2011. – №3. – Р. 1600-1625
Sara Vélez Gómez, Isaura Torres, Rubén Darío Manrique, Mauricio Duque, Juan Esteban Gallo // Aplicación farmacogenómica de los genes CYP2C19, CYP2C9 y VKORC1 implicados en el metabolismo de los fármacos clopidogrel y warfarina. Revista Colombiana de Cardiología. Volume 25. Issue 6. 2018. Pages 396- 404.
The Impact of Thyroid Disease on the Regulation, Expression, and Function of ABCB1 (MDR1/P Glycoprotein) and Consequences for the Disposition of Digoxin / O. Burk [et al.] // Clin Pharmacol Ther. – 2010. – Vol. 88, №5. – P. 685-694.
Zhou S.F. Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition//Xenobiotica. 2008, Jul. Vol.38, №7–8. P. 802–832.
Zhou S.F., Di Y.M., Chan E., Du Y.M.,Chow V.D., Xue C.C., Lai X., Wang J.C., Li C.G.,Tian M., Duan W. Clinical pharmacogenetics and potential application in personalized medicine// Curr. Drug. Metab. 2008, Oct. Vol.9, №8. P. 738–784.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.